The EGFR downstream signaling cascades themselves have been shown to regulate PD-L1 expression in different tumor entities (16–19) including HPV negative HNSCC tumor specimens that rely on a tumor-intrinsic, EGFR-directed PD-L1 expression for immune evasion (20). The gene discussed is EGFR; the disease is neoplasm.